IPO Databook: Encore Medical (EMI US) - Sep 2026
Encore Medical is a structural heart device company focused on transcatheter closure of cardiac defects, developing and marketing septal...
Encore Medical (EMI US): Synthetic Expert Call Transcript (17 Jul 2026)
Slick clinical pedigree but highly restricted OUS economics: While Encore’s technology boasts over 35,000 successful transcatheter defect closure...
No more insights